GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (OTCPK:NVSEF) » Definitions » FCF Yield %

Novartis AG (Novartis AG) FCF Yield % : 4.96 (As of Apr. 27, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Novartis AG FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Novartis AG's Trailing 12-Month Free Cash Flow is $10,148 Mil, and Market Cap is $200,096 Mil. Therefore, Novartis AG's FCF Yield % for today is 4.96%.

The historical rank and industry rank for Novartis AG's FCF Yield % or its related term are showing as below:

NVSEF' s FCF Yield % Range Over the Past 10 Years
Min: 4.45   Med: 6.04   Max: 7.7
Current: 4.96


During the past 13 years, the highest FCF Yield % of Novartis AG was 7.70%. The lowest was 4.45%. And the median was 6.04%.

NVSEF's FCF Yield % is ranked better than
78.89% of 1080 companies
in the Drug Manufacturers industry
Industry Median: -0.65 vs NVSEF: 4.96

Novartis AG's FCF Margin % for the quarter that ended in Mar. 2024 was 9.15%.


Novartis AG FCF Yield % Historical Data

The historical data trend for Novartis AG's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG FCF Yield % Chart

Novartis AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.60 5.52 6.76 6.51 5.73

Novartis AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.67 5.52 9.41 3.45 2.25

Competitive Comparison of Novartis AG's FCF Yield %

For the Drug Manufacturers - General subindustry, Novartis AG's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novartis AG's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Novartis AG's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Novartis AG's FCF Yield % falls into.



Novartis AG FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Novartis AG's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=11705 / 204403
=5.73%

Novartis AG's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=1109 * 4 / 196919.9691
=2.25%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novartis AG FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Novartis AG FCF Yield % Related Terms

Thank you for viewing the detailed overview of Novartis AG's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Novartis AG (Novartis AG) Business Description

Address
Lichtstrasse 35, Basel, CHE, 4056
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.